Literature DB >> 20589647

Analysis of liver transplant outcomes for United Network for Organ Sharing recipients 60 years old or older identifies multiple model for end-stage liver disease-independent prognostic factors.

Thomas A Aloia1, Richard Knight, A Osama Gaber, R Mark Ghobrial, John A Goss.   

Abstract

Older recipient age is associated with worse posttransplant survival. Although the median age of liver disease patients undergoing orthotopic liver transplantation (OLT) continues to rise, prognostic factors for posttransplant survival specific to older patients have not been defined. To address this issue, the United Network for Organ Sharing/Organ Procurement and Transplantation Network outcome database was searched to identify prognostic factors for the 8070 liver recipients 60 years old or older who underwent transplantation from 1994 to 2005. Prognostic factors were assessed with univariate analysis and multivariate modeling. The 5 strongest prognostic variables (ventilator status, diabetes mellitus, hepatitis C virus, creatinine levels >/=1.6 mg/dL, and recipient and donor age >or=120 years) were aggregated to define a novel older recipient prognostic score (ORPS). The overall 1- and 5-year posttransplant survival rates were 83% and 67%, respectively. The risk model, created by the assignment of 1 point to each ORPS factor, stratified patient outcomes into distinct prognostic groups at the 1-, 3-, and 5-year posttransplant time points (P < 0.001). The 5-year survival rates for patients with ORPS values of 0, 1, and 2 points were 75%, 69%, and 58%, respectively. Patients who underwent transplantation with an ORPS > 2 points consistently experienced 5-year survival rates of less than 50%. In conclusion, in liver transplant recipients 60 years old or older, the ORPS was able to predict significant and clinically relevant differences in posttransplant survival. By optimization of donor selection for recipients over the age of 60 years, clinical utilization of the ORPS model may enhance organ utilization for all patients awaiting OLT. (c) 2010 AASLD.

Entities:  

Mesh:

Year:  2010        PMID: 20589647     DOI: 10.1002/lt.22098

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  23 in total

1.  Age is not a contraindication for orthotopic liver transplantation: a single institution experience with recipients older than 75 years.

Authors:  C Burcin Taner; Ryan L Ung; Barry G Rosser; Jaime Aranda-Michel
Journal:  Hepatol Int       Date:  2011-06-18       Impact factor: 6.047

Review 2.  Aging and liver disease.

Authors:  In Hee Kim; Tatiana Kisseleva; David A Brenner
Journal:  Curr Opin Gastroenterol       Date:  2015-05       Impact factor: 3.287

3.  Defining readmission risk factors for liver transplantation recipients.

Authors:  Neil Shankar; Paul Marotta; William Wall; Mamoun Albasheer; Roberto Hernandez-Alejandro; Natasha Chandok
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-09

4.  Functional impairment in older liver transplantation candidates: From the functional assessment in liver transplantation study.

Authors:  Connie W Wang; Kenneth E Covinsky; Sandy Feng; Hilary Hayssen; Dorry L Segev; Jennifer C Lai
Journal:  Liver Transpl       Date:  2015-11-06       Impact factor: 5.799

5.  Combined effects of recipient age and model for end-stage liver disease score on liver transplantation outcomes.

Authors:  Suzanne R Sharpton; Sandy Feng; Bilal Hameed; Francis Yao; Jennifer C Lai
Journal:  Transplantation       Date:  2014-09-15       Impact factor: 4.939

6.  Medication adherence and rejection rates in older vs younger adult liver transplant recipients.

Authors:  Emily A Leven; Rachel Annunziato; Jacqueline Helcer; Sarah R Lieber; Christopher S Knight; Catherine Wlodarkiewicz; Rainier P Soriano; Sander S Florman; Thomas D Schiano; Eyal Shemesh
Journal:  Clin Transplant       Date:  2017-05-03       Impact factor: 2.863

7.  Is liver transplantation safe and effective in elderly (≥70 years) recipients? A case-controlled analysis.

Authors:  Gregory C Wilson; R Cutler Quillin; Koffi Wima; Jeffrey M Sutton; Richard S Hoehn; Dennis J Hanseman; Ian M Paquette; Flavio Paterno; E Steve Woodle; Daniel E Abbott; Shimul A Shah
Journal:  HPB (Oxford)       Date:  2014-08-06       Impact factor: 3.647

8.  Projected future increase in aging hepatitis C virus-infected liver transplant candidates: a potential effect of hepatocellular carcinoma.

Authors:  Scott W Biggins; Kiran M Bambha; Norah A Terrault; John Inadomi; Stephen Shiboski; Jennifer L Dodge; Jane Gralla; Hugo R Rosen; John P Roberts
Journal:  Liver Transpl       Date:  2012-12       Impact factor: 5.799

9.  Solid-organ transplantation in older adults: current status and future research.

Authors:  M Abecassis; N D Bridges; C J Clancy; M A Dew; B Eldadah; M J Englesbe; M F Flessner; J C Frank; J Friedewald; J Gill; C Gries; J B Halter; E L Hartmann; W R Hazzard; F M Horne; J Hosenpud; P Jacobson; B L Kasiske; J Lake; R Loomba; P N Malani; T M Moore; A Murray; M-H Nguyen; N R Powe; P P Reese; H Reynolds; M D Samaniego; K E Schmader; D L Segev; A S Shah; L G Singer; J A Sosa; Z A Stewart; J C Tan; W W Williams; D W Zaas; K P High
Journal:  Am J Transplant       Date:  2012-09-07       Impact factor: 8.086

10.  Effect of the clinical course of acute-on-chronic liver failure prior to liver transplantation on post-transplant survival.

Authors:  Vinay Sundaram; Shannon Kogachi; Robert J Wong; Constantine J Karvellas; Brett E Fortune; Nadim Mahmud; Josh Levitsky; Robert S Rahimi; Rajiv Jalan
Journal:  J Hepatol       Date:  2019-10-25       Impact factor: 25.083

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.